Hiroshi Sakakibara

Hiroshi Sakakibara

Auto-generated profile, based on publicly available information

Hiroshi Sakakibara

Department of General Pediatrics Tokyo Metropolitan Children's Medical Center Tokyo Japan

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2021 in Circulation: Cardiovascular Quality and Outcomes
Verified
Journal Article
Closed access
PDF file
KMKoichi Miyata
Koichi Miyata
MMMasaru Miura
Masaru Miura
TKTetsuji Kaneko
Tetsuji Kaneko
YMYoshihiko Morikawa
Yoshihiko Morikawa
HSHiroshi Sakakibara
Hiroshi Sakakibara
HYHiroyuki Yamagishi
Hiroyuki Yamagishi
Background: Coronary artery abnormalities (CAAs) still occur in patients with Kawasaki disease receiving intensified treatment with corticosteroids. We aimed to determine the risk factors of CAA development and resistance to intensified treatment in Post RAISE (Prospective Observational Study on Stratified Treatment With Immunoglobulin Plus Steroid Efficacy for Kawasaki Disease)—the largest prospective cohort of Kawasaki disease patients to date. Methods: In Post RAISE, 2648 consecutive patients with Kawasaki disease were enrolled. The present study analyzed 724 patients predicted to be intravenous immunoglobulin (IVIG) nonresponders (Kobayashi score ≥5) who received intensified treatment consisting of IVIG plus prednisolone. The association between the baseline characteristics and CAA at 1 month after disease onset was examined. The association between the baseline characteristics and treatment resistance was also investigated. Results: Maximum Z score at baseline ≥2.5 (odds ratio, 3.4 [95% CI, 1.5–7.8]), age at fever onset <1 year (odds ratio, 3.4 [95% CI, 1.6–7.4]), and nonresponsiveness to IVIG plus prednisolone treatment (odds ratio, 6.8 [95% CI, 3.3–14.0]) were independent predictors of CAA development. Nonresponsiveness to IVIG plus prednisolone was significantly associated with 8 baseline variables. Baseline total bilirubin (odds ratio, 1.4 [95% CI, 1.2–1.7]) was the only significant independent predictor other than the variables included in the Kobayashi score, enabling treatment resistance to be identified at diagnosis. The area under the ROC curve was 0.74 (95% CI, 0.69–0.79). At a cutoff point of 1.0, the sensitivity and specificity for predicting treatment resistance were 71% and 65%, respectively. Conclusions: In Post RAISE, younger age at fever onset, a larger maximum Z score at baseline, and nonresponsiveness to IVIG plus prednisolone were risk factors significantly associated with CAA development. Nonresponders were able to be identified at diagnosis based on the total bilirubin value. To prevent CAA, more intensified or adjunctive therapies using other agents, such as pulsed methylprednisolone, ciclosporin, infliximab, and Anakinra, should be considered for patients with these risk factors. Registration: URL: https://www.umin.ac.jp/ctr/ ; Unique identifier: UMIN000007133.

17 June 2021 in The Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
KMKoichi Miyata
Koichi Miyata
MMMasaru Miura
Masaru Miura
TKTetsuji Kaneko
Tetsuji Kaneko
YMYoshihiko Morikawa
Yoshihiko Morikawa
TMTakahiro Matsushima
Takahiro Matsushima
HYHiroyuki Yamagishi
Hiroyuki Yamagishi

1 September 2021 in Vaccine
Verified
Journal Article
Closed access
YMYoshihiko Morikawa
Yoshihiko Morikawa
HSHiroshi Sakakibara
Hiroshi Sakakibara
TKTakahisa Kimiya
Takahisa Kimiya
TOToshimasa Obonai
Toshimasa Obonai
MMMasaru Miura
Masaru Miura

11 August 2022 in World Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
YMYoshihiko Morikawa
Yoshihiko Morikawa
HSHiroshi Sakakibara
Hiroshi Sakakibara
MMMasaru Miura
Masaru Miura

1 January 2026 in Pediatrics International
Verified
Journal Article
Closed access
PDF file
NKNatsuki Koriyama
Natsuki Koriyama
YMYo Murata
Yo Murata
SSShoichiro Shirane
Shoichiro Shirane
MOMadoka Okabe
Madoka Okabe
SAShogo Akahoshi
Shogo Akahoshi
HSHiroshi Sakakibara
Hiroshi Sakakibara

6 July 2026 in Diagnosis
Verified
Journal Article
Closed access
MFMizuka Fu
Mizuka Fu
TNToshiki Nakamura
Toshiki Nakamura
SKShun Kishibe
Shun Kishibe
YHYusuke Hagiwara
Yusuke Hagiwara
TSTaro Shimizu
Taro Shimizu
HSHiroshi Sakakibara
Hiroshi Sakakibara
Objectives: Diagnostic errors are multifactorial and tend to occur frequently in the emergency department. Pediatric emergency care presents unique challenges, particularly in the evaluation of trauma in preverbal infants who cannot adequately describe their symptoms. Herein, we present the case of an infant in whom irritability following minor head trauma was incorrectly diagnosed. Case presentation: A 1-year-6-month-old boy presented to the emergency department with irritability following minor head trauma. The initial evaluation focused on the head trauma, and the child’s irritability was attributed to an upper respiratory tract infection and the effect of the unfamiliar examination environment. The patient was discharged, but several hours later, he returned because of right thigh swelling, which revealed a femoral fracture. Root cause analysis using a fishbone diagram identified the contributing factors to the delayed diagnosis as the vague, clinical presentation of pediatric trauma, multiple cognitive biases, and the role of family concerns in clinical reasoning. Conclusions: In preverbal children, behavioral changes, such as a sudden refusal to walk, may indicate a serious pathology. Clinicians should avoid anchoring, perform a thorough, whole-body assessment, and take the family’s concerns into consideration to ensure diagnostic accuracy in cases of pediatric trauma.